A Comprehensive Practice Guideline for Magnetic Resonance Imaging Compatibility in Implanted Neuromodulation Devices.
Deep brain stimulation
MRI
dorsal column stimulation
dorsal root ganglion stimulation
guideline
intrathecal pump
medical devices
spinal cord stimulation
Journal
Neuromodulation : journal of the International Neuromodulation Society
ISSN: 1525-1403
Titre abrégé: Neuromodulation
Pays: United States
ID NLM: 9804159
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
received:
25
04
2020
revised:
06
06
2020
accepted:
16
06
2020
pubmed:
19
8
2020
medline:
31
7
2021
entrez:
19
8
2020
Statut:
ppublish
Résumé
The evolution of neuromodulation devices in order to enter magnetic resonance imaging (MRI) scanners has been one of understanding limitations, engineering modifications, and the development of a consensus within the community in which the FDA could safely administer labeling for the devices. In the initial decades of neuromodulation, it has been contraindicated for MRI use with implanted devices. In this review, we take a comprehensive approach to address all the major products currently on the market in order to provide physicians with the ability to determine when an MRI can be performed for each type of device implant. We have prepared a narrative review of MRI guidelines for currently marketed implanted neuromodulation devices including spinal cord stimulators, intrathecal drug delivery systems, peripheral nerve stimulators, deep brain stimulators, vagal nerve stimulators, and sacral nerve stimulators. Data sources included relevant literature identified through searches of PubMed, MEDLINE/OVID, SCOPUS, and manual searches of the bibliographies of known primary and review articles, as well as manufacturer-provided information. Guidelines and recommendations for each device and their respective guidelines for use in and around MR environments are presented. This is the first comprehensive guideline with regards to various devices in the market and MRI compatibility from the American Society of Pain and Neuroscience.
Identifiants
pubmed: 32809275
doi: 10.1111/ner.13233
pii: S1094-7159(21)00219-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
893-911Informations de copyright
© 2020 International Neuromodulation Society.
Références
Falowski SM. The ongoing debate of the utility of magnetic resonance imaging conditional neuromodulation devices. Neuromodulation 2015;18:337-338.
Tsai LL, Grant AK, Mortele KJ, Kung JW, Smith MP. A practical guide to MR imaging safety: what radiologists need to know. Radiogr Rev Publ Radiol Soc N Am Inc 2015;35:1722-1737.
Smith-Bindman R, Kwan ML, Marlow EC et al. Trends in use of medical imaging in US health care systems and in Ontario, Canada, 2000-2016. JAMA 2019;322:843-856.
Desai MJ, Hargens LM, Breitenfeldt MD et al. The rate of magnetic resonance imaging in patients with spinal cord stimulation. Spine 2015;40:E531-E537.
Woods TO. Standards for medical devices in MRI: present and future. J Magn Reson Imaging 2007;26:1186-1189.
F04 Committee. Practice for Marking Medical Devices and Other Items for Safety in the Magnetic Resonance Environment [Internet]. ASTM International; [cited 2020 Mar 23]. http://www.astm.org/cgi-bin/resolver.cgi?F2503-20
Harned ME, Gish B, Zuelzer A, Grider JS. Anesthetic considerations and perioperative management of spinal cord stimulators: literature review and initial recommendations. Pain Physician 2017;20:319-329.
Moeschler SM, Sanders RA, Hooten WM, Hoelzer BC. Spinal cord stimulator explantation for magnetic resonance imaging: a case series. Neuromodulation 2015;18:285-288. discussion 288.
Sammet S. Magnetic resonance safety. Abdom Radiol N Y 2016;41:444-451.
Coskun O. Magnetic resonance imaging and safety aspects. Toxicol Ind Health 2011;27:307-313.
Landrigan C. Preventable deaths and injuries during magnetic resonance imaging. N Engl J Med 2001;345:1000-1001.
Bongers S, Slottje P, Kromhout H. Hearing loss associated with repeated MRI acquisition procedure-related acoustic noise exposure: an occupational cohort study. Occup Environ Med 2017;74:776-784.
Health C for D and R. Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices - Guidance for Industry and Food and Drug Administration Staff [Internet]. U.S. Food and Drug Administration. FDA; 2020 [cited 2020 Mar 23]. http://www.fda.gov/regulatory-information/search-fda-guidance-documents/criteria-significant-risk-investigations-magnetic-resonance-diagnostic-devices-guidance-industry-and
Baker KB, Nyenhuis JA, Hrdlicka G, Rezai AR, Tkach JA, Shellock FG. Neurostimulation systems: assessment of magnetic field interactions associated with 1.5- and 3-Tesla MR systems. J Magn Reson Imaging 2005;21:72-77.
De Andres J, Valía JC, Cerda-Olmedo G et al. Magnetic resonance imaging in patients with spinal neurostimulation systems. Anesthesiology 2007;106:779-786.
Liem LA, van Dongen VC. Magnetic resonance imaging and spinal cord stimulation systems. Pain 1997;70:95-97.
Thornton JS. Technical challenges and safety of magnetic resonance imaging with in situ neuromodulation from spine to brain. Eur J Paediatr Neurol 2017;21:232-241.
Walsh KM, Machado AG, Krishnaney AA. Spinal cord stimulation: a review of the safety literature and proposal for perioperative evaluation and management. Spine J 2015;15:1864-1869.
Deogaonkar M, Sharma M, Oluigbo C et al. Spinal cord stimulation (SCS) and functional magnetic resonance imaging (fMRI): modulation of cortical connectivity with therapeutic SCS. Neuromodulation 2016;19:142-153.
Moens M, Droogmans S, Spapen H et al. Feasibility of cerebral magnetic resonance imaging in patients with externalised spinal cord stimulator. Clin Neurol Neurosurg 2012;114:135-141.
Coffey RJ, Kalin R, Olsen JM. Magnetic resonance imaging conditionally safe neurostimulation leads: investigation of the maximum safe lead tip temperature. Neurosurgery 2014;74:215-224. discussion 224-225.
Mutter UM, Bellut D, Porchet F, Schuknecht B. Spinal magnetic resonance imaging with reduced specific absorption rate in patients harbouring a spinal cord stimulation device - a single-centre prospective study analysing safety, tolerability and image quality. Acta Neurochir 2013 Dec;155:2327-2332.
Kosturakis A, Gebhardt R. SynchroMed II intrathecal pump memory errors due to repeated magnetic resonance imaging. Pain Physician 2012;15:475-477.
Diehn FE, Wood CP, Watson RE, Mauck WD, Burke MM, Hunt CH. Clinical safety of magnetic resonance imaging in patients with implanted SynchroMed EL infusion pumps. Neuroradiology 2011;53:117-122.
De Andres J, Villanueva V, Palmisani S et al. The safety of magnetic resonance imaging in patients with programmable implanted intrathecal drug delivery systems: a 3-year prospective study. Anesth Analg 2011;112:1124-1129.
Deer TR, Pope JE, Hayek SM et al. The Polyanalgesic Consensus Conference (PACC): recommendations on intrathecal drug infusion systems best Practices and guidelines. Neuromodulation 2017;20:96-132.
Rauck R, Deer T, Rosen S et al. Long-term follow-up of a novel implantable programmable infusion pump. Neuromodulation 2013;16:163-167.
Indications-Safety-Warnings.pdf [Internet]. [cited 2020 Mar 23]. https://flowonix.com/sites/default/files/Indications-Safety-Warnings.pdf
Kovacs S, Peeters R, De Ridder D, Plazier M, Menovsky T, Sunaert S. Central effects of occipital nerve electrical stimulation studied by functional magnetic resonance imaging. Neuromodulation 2011;14:46-57.
Shellock FG, Zare A, Ilfeld BM, Chae J, Strother RB. In vitro magnetic resonance imaging evaluation of fragmented, open-coil, percutaneous peripheral nerve stimulation leads. Neuromodulation 2018;21:276-283.
Oluigbo CO, Rezai AR. Magnetic resonance imaging safety of deep brain stimulator devices. Handb Clin Neurol 2013;116:73-76.
Rezai AR, Phillips M, Baker KB et al. Neurostimulation system used for deep brain stimulation (DBS): MR safety issues and implications of failing to follow safety recommendations. Invest Radiol 2004;39:300-303.
Spiegel J, Fuss G, Backens M et al. Transient dystonia following magnetic resonance imaging in a patient with deep brain stimulation electrodes for the treatment of Parkinson disease. Case report. J Neurosurg 2003;99:772-774.
Henderson JM, Tkach J, Phillips M, Baker K, Shellock FG, Rezai AR. Permanent neurological deficit related to magnetic resonance imaging in a patient with implanted deep brain stimulation electrodes for Parkinson's disease: case report. Neurosurgery 2005;57:E1063 discussion E1063.
Franceschi AM, Wiggins GC, Mogilner AY, Shepherd T, Chung S, Lui YW. Optimized, minimal specific absorption rate MRI for high-resolution imaging in patients with implanted deep brain stimulation electrodes. AJNR Am J Neuroradiol 2016;37:1996-2000.
Benbadis SR, Nyhenhuis J, Tatum WO, Murtagh FR, Gieron M, Vale FL. MRI of the brain is safe in patients implanted with the vagus nerve stimulator. Seizure 2001;10:512-515.
Rösch J, Hamer HM, Mennecke A et al. 3T-MRI in patients with pharmacoresistant epilepsy and a vagus nerve stimulator: a pilot study. Epilepsy Res 2015;110:62-70.
de Jonge JC, Melis GI, Gebbink TA, de Kort GAP, Leijten FSS. Safety of a dedicated brain MRI protocol in patients with a vagus nerve stimulator. Epilepsia 2014;55:e112-e115.
Gorny KR, Bernstein MA, Watson RE. 3 tesla MRI of patients with a vagus nerve stimulator: initial experience using a T/R head coil under controlled conditions. J Magn Reson Imaging JMRI 2010;31:475-481.
Shellock FG, Begnaud J, Inman DM. Vagus nerve stimulation therapy system: in vitro evaluation of magnetic resonance imaging-related heating and function at 1.5 and 3 tesla. Neuromodulation 2006;9:204-213.
Roebling R, Huch K, Kassubek J, Lerche H, Weber Y. Cervical spinal MRI in a patient with a vagus nerve stimulator (VNS). Epilepsy Res 2009;84:273-275.
Lopez de Heredia L, Meagher TMM, Jamous MA, Hughes RJ. Long-term effect of MRI on sacral anterior root stimulator: the stoke Mandeville experience. Spinal Cord 2012;50:294-297.
Elkelini MS, Hassouna MM. Safety of MRI at 1.5 Tesla in patients with implanted sacral nerve neurostimulator. Eur Urol 2006;50:311-316.
Chermansky CJ, Krlin RM, Holley TD, Woo HH, Winters JC. Magnetic resonance imaging following InterStim®: an institutional experience with imaging safety and patient satisfaction. NeurourolUrodyn 2011;30:1486-1488.
Lloyd JC, Gill BC, Pizarro-Berdichevsky J, Goldman HB. Removal of sacral nerve stimulation devices for magnetic resonance imaging: what happens next? Neuromodulation 2017;20:836-840.
Falowski S, Safriel Y, Ryan MP, Hargens L. The rate of magnetic resonance imaging in patients with deep brain stimulation. Stereotact Funct Neurosurg 2016;94:147-153.
M961343A_f_001_view.pdf [Internet]. [cited 2020 Mar 23]. http://manuals.medtronic.com/content/dam/emanuals/neuro/M961343A_f_001_view.pdf